Changes in Bone Mass After Discontinuation of Preexposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine in Young Men Who Have Sex With Men: Extension Phase Results of Adolescent Trials Network Protocols 110 and 113.
adolescents
bone mineral density
men who have sex with men
preexposure prophylaxis
tenofovir disoproxil fumarate
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213
Informations de publication
Date de publication:
03 02 2020
03 02 2020
Historique:
received:
24
01
2019
accepted:
06
06
2019
pubmed:
11
6
2019
medline:
7
1
2021
entrez:
11
6
2019
Statut:
ppublish
Résumé
Human immunodeficiency virus-seronegative men aged 15-22 years who lost bone mineral density (BMD) during tenofovir disoproxil fumarate/emtricitabine preexposure prophylaxis (PrEP) showed BMD recovery 48 weeks following PrEP discontinuation. Lumbar spine and whole body BMD z-scores remained below baseline 48 weeks off PrEP in participants aged 15-19 years. Clinical Trials Registration. NCT01772823 (ATN 110) and NCT01769456 (ATN 113).
Identifiants
pubmed: 31179503
pii: 5513182
doi: 10.1093/cid/ciz486
pmc: PMC7319267
doi:
Substances chimiques
Anti-HIV Agents
0
Tenofovir
99YXE507IL
Emtricitabine
G70B4ETF4S
Banques de données
ClinicalTrials.gov
['NCT01772823', 'NCT01769456']
Types de publication
Clinical Trial
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
687-691Informations de copyright
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Références
J Acquir Immune Defic Syndr. 2017 Oct 1;76(2):177-182
pubmed: 28639995
PLoS One. 2016 Dec 12;11(12):e0166982
pubmed: 27941989
J Clin Endocrinol Metab. 2010 Apr;95(4):1690-8
pubmed: 20194709
Clin Infect Dis. 2015 Aug 15;61(4):572-80
pubmed: 25908682
AIDS Res Hum Retroviruses. 2019 Jul;35(7):608-614
pubmed: 30907095
AIDS. 2012 Apr 24;26(7):825-31
pubmed: 22301411
J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):287-94
pubmed: 26866954
AIDS Res Hum Retroviruses. 2019 Feb;35(2):123-128
pubmed: 30280906
PLoS One. 2011;6(8):e23688
pubmed: 21897852
J Infect Dis. 2013 Feb 1;207(3):386-91
pubmed: 23148289
Osteoporos Int. 2000;11(12):985-1009
pubmed: 11256898
Clin Infect Dis. 2012 Aug;55(3):461-8
pubmed: 22573848
JAMA Pediatr. 2017 Nov 1;171(11):1063-1071
pubmed: 28873128
J Acquir Immune Defic Syndr. 2017 Dec 15;76(5):539-546
pubmed: 28902705
Ann Intern Med. 2015 Jun 16;162(12):815-24
pubmed: 26075752
Clin Infect Dis. 2017 Feb 1;64(3):317-325
pubmed: 28013265
J Acquir Immune Defic Syndr. 2017 Jan 1;74(1):21-29
pubmed: 27632233
PLoS One. 2014 Mar 13;9(3):e90111
pubmed: 24625530
J Acquir Immune Defic Syndr. 2019 Feb 1;80(2):214-223
pubmed: 30422911
Lancet Infect Dis. 2014 Sep;14(9):820-9
pubmed: 25065857
J Pharm Biomed Anal. 2014 Jan;88:144-51
pubmed: 24055850
J Virus Erad. 2018 Oct 1;4(4):215-224
pubmed: 30515300
J Clin Endocrinol Metab. 2011 Oct;96(10):3160-9
pubmed: 21917867
Clin Infect Dis. 2018 Jan 06;66(2):220-228
pubmed: 29020329